Adil Supiyev1, Alibek Kossumov2, Aliya Kassenova2, Talgat Nurgozhin2, Zhaxybay Zhumadilov2, Anne Peasey3, Martin Bobak4. 1. Department of Epidemiology and Public Health, University College London, London, UK; Laboratory of Epidemiology and Public Health, Center for life sciences, National Laboratory Astana, Nazarbayev University, Astana, Kazakhstan. 2. Laboratory of Epidemiology and Public Health, Center for life sciences, National Laboratory Astana, Nazarbayev University, Astana, Kazakhstan. 3. Department of Epidemiology and Public Health, University College London, London, UK. 4. Department of Epidemiology and Public Health, University College London, London, UK. Electronic address: m.bobak@ucl.ac.uk.
Abstract
AIMS: The evidence on the prevalence and distribution of diabetes and its determinants in Central Asia is sparse. The aim of the present study was to investigate the prevalence, awareness, treatment, and control of diabetes and factors associated with these characteristics in the population of Astana (capital) city and adjacent rural area in Kazakhstan. METHODS: Participants aged 50-75 years old, residing in Astana city (the capital) and Akmol village were invited to participate in a cross-sectional study. The subjects were randomly selected from polyclinic registers. A total of 953 adults were interviewed (response rate 59%), and their fasting plasma glucose, blood pressure, height and weight were measured. Diabetes was defined as fasting plasma glucose (FPG) ≥ 7.0 mmol/l (126 mg/dl) and/or being on diabetes medication. RESULTS: The overall prevalence of diabetes was 12.5%, and it was almost twice higher in the urban residents (16.3%) than in the rural population (8.6%). Diabetes prevalence was associated with age, men sex, hypertension, obesity, and Russian ethnicity. Among subjects with diabetes, 72.3% were aware of their condition; 65.6% were on treatment and 27.7% had controlled fasting plasma glucose. The awareness, treatment and control of diabetes were substantially higher in the urban population and among women. CONCLUSIONS: The large differences in all diabetes indices between urban and rural regions, if confirmed in larger studies, may suggest an impact of westernised and urbanised lifestyle as well as access to health care.
AIMS: The evidence on the prevalence and distribution of diabetes and its determinants in Central Asia is sparse. The aim of the present study was to investigate the prevalence, awareness, treatment, and control of diabetes and factors associated with these characteristics in the population of Astana (capital) city and adjacent rural area in Kazakhstan. METHODS:Participants aged 50-75 years old, residing in Astana city (the capital) and Akmol village were invited to participate in a cross-sectional study. The subjects were randomly selected from polyclinic registers. A total of 953 adults were interviewed (response rate 59%), and their fasting plasma glucose, blood pressure, height and weight were measured. Diabetes was defined as fasting plasma glucose (FPG) ≥ 7.0 mmol/l (126 mg/dl) and/or being on diabetes medication. RESULTS: The overall prevalence of diabetes was 12.5%, and it was almost twice higher in the urban residents (16.3%) than in the rural population (8.6%). Diabetes prevalence was associated with age, men sex, hypertension, obesity, and Russian ethnicity. Among subjects with diabetes, 72.3% were aware of their condition; 65.6% were on treatment and 27.7% had controlled fasting plasma glucose. The awareness, treatment and control of diabetes were substantially higher in the urban population and among women. CONCLUSIONS: The large differences in all diabetes indices between urban and rural regions, if confirmed in larger studies, may suggest an impact of westernised and urbanised lifestyle as well as access to health care.
Authors: Adil Supiyev; Talgat Nurgozhin; Zhaxybay Zhumadilov; Anne Peasey; Jaroslav A Hubacek; Martin Bobak Journal: BMC Public Health Date: 2017-08-11 Impact factor: 3.295
Authors: Benjamin Tb Chan; Chris Rauscher; Arman M Issina; Laura H Kozhageldiyeva; Dametken D Kuzembaeva; Connie L Davis; Helena Kravchenko; Michael Hindmarsh; Jessie McGowan; Gulnara Kulkaeva Journal: Bull World Health Organ Date: 2019-01-27 Impact factor: 9.408